A total of just under NOK 183 million is now being distributed among 24 researchers, 13 of whom are affiliated to Oslo University Hospital. They were selected after independent international experts had assessed a total of 146 applications.
After the all-time fundraising record in the Pink Ribbon Campaign, more researchers than ever are receiving millions in support for vital work against breast cancer.  "Thanks to all the contributions from private individuals and businesses, from the hundreds of thousands who bought and wore the pink ribbon last year, we can now distribute a total of 47 million kroner to six outstanding breast cancer researchers", says Secretary General of the Norwegian Cancer Society, Ingrid Stenstadvold Ross.

Sigrid S. Skånland, researcher at the Institute for Cancer Research, recently published the photo book “Mennesker med kreft = People with cancer”. The book portrays 50 people with cancer and includes short quotes from each participant, both in Norwegian and English. Skånland got the idea to do the photo project after being awarded the price “Researcher of the year” in 2023. The price money (100,000 NOK) was financed by Radiumhospitalets legater and had to be spent on cancer-related activity.

“I noticed that the stereotype of cancer patients presented to us by the media does not reflect the reality. I wanted to see and show what real people with cancer are like,” Skånland says.

A Norwegian research team led by Professor Johanne Olweus has developed a new and groundbreaking method that offers the possibility of treating several aggressive forms of cancer. In an article published in Nature Immunology they propose that TCR-T cells targeting CTNNB1-S37F can serve as a basis for solid cancer immunotherapy.
The results have attracted international attention, and the research was recently featured in a major article in Norway's largest newspaper VG, entitled "Norwegian cancer study: –⁠ This is definitely a breakthrough".

The PREDI-LYNCH consortium officially launched its six-year Horizon Europe project with an in-person kickoff meeting in Heidelberg on September 18, 2025. The partners were welcomed by Project Coordinator Mev Dominguez-Valentin from the Institute for Cancer Research.
The event brought together more than 50 researchers, clinicians, and partners from across Europe. Funded under the EU Mission on Cancer, PREDI-LYNCH unites leading institutions and experts to improve screening, diagnostics, and risk prediction for individuals with a hereditary predisposition to cancer.

The National Research Archive (NVA) has replaced Cristin and is now open for both previous Cristin users and new contributors at OUS. Whether you're registering for the first time or updating your publications, NVA offers improved functionality for managing research outputs, including support for green open access and project code reporting.

Click More to learn how to get started, request editing access, and upload files for archiving.

The article "Targeting the roots of myeloid malignancies with T cell receptors" has been published online in the prestigious journal Nature Reviews Cancer.
Senior author is Johanna Olweus, head of the Experimental Immunotherapy Group at the Department of Cancer Immunology at the Insitute for Cancer Research.

The work is a collaboration with Sten Eirik Jacobsens group at Karolinska Institutet.

Link to the article (view only version)